[MEDULLARY APLASIA DURING THE USE OF 4 ANTIMITOTICS: CARYOLYSIN, MYLERAN, THIOTEPA, ENDOXAN (APROPOS OF 32 CASES)].
D000740:Anemia; D000741:Anemia, Aplastic; D050256:Antimitotic Agents; D002066:Busulfan; D003520:Cyclophosphamide; D009369:Neoplasms / Q000628:therapy*; D009588:Nitrogen Mustard Compounds; D013852:Thiotepa; D014116:Toxicology
D050256:Antimitotic Agents; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide; D013852:Thiotepa; D002066:Busulfan
ANEMIA, APLASTIC; BUSULFAN; CYCLOPHOSPHAMIDE; NEOPLASM THERAPY; NITROGEN MUSTARD COMPOUNDS; THIO-TEPA; TOXICOLOGIC REPORT
LES APLASIES M'EDULLAIRES AU COURS DE L'UTILISATION DE QUATRE ANTIMITOTIQUES: CARYOLYSINE, MYLERAN, THIOT'EPA, ENDOXAN ('A PROPOS DE 32 OBSERVATIONS)